Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder
<p>Abstract</p> <p>Background</p> <p>Inflammatory mediators in both the peripheral circulation and central nervous system (CNS) are dysregulated in major depressive disorder (MDD). Nevertheless, relatively little is known about the role of the T-helper (Th)-2 effector c...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | BMC Psychiatry |
Online Access: | http://www.biomedcentral.com/1471-244X/12/2 |
id |
doaj-7771fe8ca15242178315efe09592a91c |
---|---|
record_format |
Article |
spelling |
doaj-7771fe8ca15242178315efe09592a91c2020-11-25T00:18:55ZengBMCBMC Psychiatry1471-244X2012-01-01121210.1186/1471-244X-12-2Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorderElomaa Antti-PekkaNiskanen LeoHerzig Karl-HeinzViinamäki HeimoHintikka JukkaKoivumaa-Honkanen HeliHonkalampi KirsiValkonen-Korhonen MinnaHarvima Ilkka TLehto Soili M<p>Abstract</p> <p>Background</p> <p>Inflammatory mediators in both the peripheral circulation and central nervous system (CNS) are dysregulated in major depressive disorder (MDD). Nevertheless, relatively little is known about the role of the T-helper (Th)-2 effector cytokines interleukin (IL)-5 and IL-13 in MDD.</p> <p>Methods</p> <p>We examined the serum levels of these cytokines and a Th-1 comparison cytokine, interferon (IFN)-γ, in 116 individuals (MDD, n = 58; controls, n = 58).</p> <p>Results</p> <p>In our basic multivariate model controlling for the effects of potential confounders on the associations between MDD and the examined cytokines, each 1-unit increase in the serum IL-5 level increased the likelihood of belonging to the MDD group by 76% (OR 1.76, 95% CI 1.03-2.99, p = 0.04; model covariates: age, gender, marital status, daily smoking and alcohol use). The likelihood further increased in models additionally controlling for the effects of the use of antidepressants and NSAIDS, and a diagnosis of asthma. No such associations were detected with regard to IL-13 (OR 1.08, 95% CI 0.96-1.22, p = 0.22) or IFN-γ (OR 1.02, 95% CI 0.99-1.05, p = 0.23).</p> <p>Conclusions</p> <p>Elevated levels of IL-5, which uses the neural plasticity-related RAS GTPase-extracellular signal-regulated kinase (Ras-ERK) pathway to mediate its actions in the central nervous system (CNS), could be one of the factors underlying the depression-related changes in CNS plasticity.</p> http://www.biomedcentral.com/1471-244X/12/2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elomaa Antti-Pekka Niskanen Leo Herzig Karl-Heinz Viinamäki Heimo Hintikka Jukka Koivumaa-Honkanen Heli Honkalampi Kirsi Valkonen-Korhonen Minna Harvima Ilkka T Lehto Soili M |
spellingShingle |
Elomaa Antti-Pekka Niskanen Leo Herzig Karl-Heinz Viinamäki Heimo Hintikka Jukka Koivumaa-Honkanen Heli Honkalampi Kirsi Valkonen-Korhonen Minna Harvima Ilkka T Lehto Soili M Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder BMC Psychiatry |
author_facet |
Elomaa Antti-Pekka Niskanen Leo Herzig Karl-Heinz Viinamäki Heimo Hintikka Jukka Koivumaa-Honkanen Heli Honkalampi Kirsi Valkonen-Korhonen Minna Harvima Ilkka T Lehto Soili M |
author_sort |
Elomaa Antti-Pekka |
title |
Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder |
title_short |
Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder |
title_full |
Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder |
title_fullStr |
Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder |
title_full_unstemmed |
Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder |
title_sort |
elevated levels of serum il-5 are associated with an increased likelihood of major depressive disorder |
publisher |
BMC |
series |
BMC Psychiatry |
issn |
1471-244X |
publishDate |
2012-01-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Inflammatory mediators in both the peripheral circulation and central nervous system (CNS) are dysregulated in major depressive disorder (MDD). Nevertheless, relatively little is known about the role of the T-helper (Th)-2 effector cytokines interleukin (IL)-5 and IL-13 in MDD.</p> <p>Methods</p> <p>We examined the serum levels of these cytokines and a Th-1 comparison cytokine, interferon (IFN)-γ, in 116 individuals (MDD, n = 58; controls, n = 58).</p> <p>Results</p> <p>In our basic multivariate model controlling for the effects of potential confounders on the associations between MDD and the examined cytokines, each 1-unit increase in the serum IL-5 level increased the likelihood of belonging to the MDD group by 76% (OR 1.76, 95% CI 1.03-2.99, p = 0.04; model covariates: age, gender, marital status, daily smoking and alcohol use). The likelihood further increased in models additionally controlling for the effects of the use of antidepressants and NSAIDS, and a diagnosis of asthma. No such associations were detected with regard to IL-13 (OR 1.08, 95% CI 0.96-1.22, p = 0.22) or IFN-γ (OR 1.02, 95% CI 0.99-1.05, p = 0.23).</p> <p>Conclusions</p> <p>Elevated levels of IL-5, which uses the neural plasticity-related RAS GTPase-extracellular signal-regulated kinase (Ras-ERK) pathway to mediate its actions in the central nervous system (CNS), could be one of the factors underlying the depression-related changes in CNS plasticity.</p> |
url |
http://www.biomedcentral.com/1471-244X/12/2 |
work_keys_str_mv |
AT elomaaanttipekka elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT niskanenleo elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT herzigkarlheinz elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT viinamakiheimo elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT hintikkajukka elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT koivumaahonkanenheli elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT honkalampikirsi elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT valkonenkorhonenminna elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT harvimailkkat elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder AT lehtosoilim elevatedlevelsofserumil5areassociatedwithanincreasedlikelihoodofmajordepressivedisorder |
_version_ |
1725374266937966592 |